This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (non-eHealth) (403) Clinical Cancer Research (116) Innovations and Technology in Cancer Care (531) Cancer and Clinical Trials (41) Cancer Survivorship (334) Lung Cancer (66) Postoperative Monitoring and Telemonitoring (190) Complementary and Alternative Medicine (94)

Published on in Vol 14 (2025)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/66342, first published .
Efficacy of Fuzheng Quxie Formula Against Postoperative Metastasis of Lung Cancer in Stage IIA-IIIA With Negative Driver Genes: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial

Efficacy of Fuzheng Quxie Formula Against Postoperative Metastasis of Lung Cancer in Stage IIA-IIIA With Negative Driver Genes: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial

Efficacy of Fuzheng Quxie Formula Against Postoperative Metastasis of Lung Cancer in Stage IIA-IIIA With Negative Driver Genes: Protocol for a Multicenter, Double-Blind, Randomized Controlled Trial

Authors of this article:

Fan Xu1 Author Orcid Image ;   Yun Yang1 Author Orcid Image ;   Yinbin Luo1 Author Orcid Image ;   Bin Luo1 Author Orcid Image ;   Jialiang Yao1 Author Orcid Image ;   Yiyang Zhou1 Author Orcid Image ;   Minghua Li1 Author Orcid Image ;   Jianchun Wu1 Author Orcid Image ;   Wenfei Shi1 Author Orcid Image ;   Lei Jiang2 Author Orcid Image ;   Qian Huang3 Author Orcid Image ;   Wentao Fang4 Author Orcid Image ;   Zhihong Fang1 Author Orcid Image ;   Yan Li1 Author Orcid Image ;   Jianhui Tian1 Author Orcid Image
Article Authors Cited by Tweetations Metrics
All Time | Last Month | Last Six Months | Last Year
There are currently no tweets available for this article within the specified range.